Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

COVID-19 Ad Intervention

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04555122
Recruitment Status : Not yet recruiting
First Posted : September 18, 2020
Last Update Posted : September 23, 2020
Sponsor:
Collaborators:
City University of Hong Kong
University of California, Los Angeles
Information provided by (Responsible Party):
Sean D Young, University of California, Irvine

Brief Summary:
This study will provide advertisements to (de-identified) participants and track (de-identified) movement patterns to learn whether the ads increase adherence to stay-at-home orders.

Condition or disease Intervention/treatment Phase
Social Distance Behavioral: Social Distancing Advertisements Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 52500 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Other
Official Title: COVID-19 Ad Intervention for Social Distancing
Estimated Study Start Date : September 29, 2020
Estimated Primary Completion Date : May 28, 2022
Estimated Study Completion Date : July 28, 2022

Arm Intervention/treatment
Experimental: Intervention Group
Advertisements will be sent to participants mobile devices to attempt to increase adherence to stay-at-home orders and social distancing. There are 3 types of advertisements. This will occur for 7 days.
Behavioral: Social Distancing Advertisements
Participants will receive 3 types of advertisements to increase social distancing/staying at home.

No Intervention: Control Group
Control Group will be people who will not receive any advertisements.



Primary Outcome Measures :
  1. Mobility [ Time Frame: 7 days ]
    Amount of time that participants are outside of their primary location/home



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 18 years of age or older (as identified by company running advertisements); recent visit to a non-essential location; agreed to terms and conditions of websites allowing advertisements

Exclusion Criteria:

-


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04555122


Contacts
Layout table for location contacts
Contact: Arjuna Ugarte predictiontechnology@hs.uci.edu

Locations
Layout table for location information
United States, California
UC Irvine
Irvine, California, United States, 92617
Contact: Arjuna Dugarte       predictiontechnology@hs.uci.edu   
Sponsors and Collaborators
University of California, Irvine
City University of Hong Kong
University of California, Los Angeles
Layout table for additonal information
Responsible Party: Sean D Young, Associate Professor of Emergency Medicine and Informatics, University of California, Irvine
ClinicalTrials.gov Identifier: NCT04555122    
Other Study ID Numbers: COVID-Ad
First Posted: September 18, 2020    Key Record Dates
Last Update Posted: September 23, 2020
Last Verified: September 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No